Servier



Servier
The leading French independent pharmaceutical company
Founded 
HeadquartersNeuilly-sur-Seine, France
Key people 
IndustryPharmaceutical
ProductsReference products for diseases of major importance
Revenue 
Operating income 
Net income 
Employees20 000 employees worldwide, including 2600 in Research and Development
SloganLife through Discovery
Websitewww.servier.com

Servier Laboratories is a privately owned French diabetes and clinical depression.[1] The consolidated turnover for the 2005/2006 financial year was €3.3 billion. Servier is the leading French independent pharmaceutical company, and the second French pharmaceutical company worldwide. It has branches in 140 countries, with 82% of its sales being achieved internationally.[1]

The company reports that almost 25% of its turnover is invested in research and development. It has 20 000 employees worldwide, of whom 2650 in research and development. 670 million drug boxes were produced for patients by the production sites in 2006.[1]

The Servier Clinical Support Unit in Gidy (near Orleans) is the largest unit of its kind in Europe for the production of drugs for clinical trials.[2]

Product portfolio

Notable products include the SSRE).[3]

ARCALION NATRILIX SR
ARTEX PNEUMOREL
COVERSYL PRETERAX - BIPRETERAX (perindopril with indapamide)
DAFLON 500 PROCORALAN
DIAMICRON MR PROTELOS
PSEUDOPHAGE
GLUCIDORAL STABLON
HYPERIUM TRIVASTAL RETARD
LOCABIOTAL VASTAREL MR
VECTARION
MUPHORAN VITATHION (vitamins)

References

  1. ^ a b c SERVIER - Pharmaceutical company specialized in cardiology, diabetes, rheumatology, depression. Retrieved on 2007-07-08.
  2. ^ Servier UK - Key figures. Retrieved on 2007-07-08.
  3. ^ SERVIER - product portfolio. Retrieved on 2007-07-08.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Servier". A list of authors is available in Wikipedia.